High Resolution Rate in Viral Conjunctivitis Almost 80% of patients virus free by day 6

Almost a third of patients with adenoviral conjunctivitis had clinical resolution within 6 days when treated with dexamethasone/povidone-iodine ophthalmic suspension (SHP640) and almost 80% had viral eradication, according to a randomized trial reported here. Virus eradication occurred as early as 3 days among patients treated with povidone-iodine, with or without dexamethasone. Treatment-emergent adverse events occurred more often with SHP640 compared with a vehicle solution administered to a control group, Abhijit Narvekar, MBBS, DPM, of Shire Pharmaceuticals in Lexington Massachusetts, reported at the American Academy of Optometry (AAOpt) meeting here. "No medications are currently approved in the U.S. for adenoviral conjunctivitis, and infected patients can easily transmit the disease to others," Narvekar said at an AAOpt press briefing. https://www.medpagetoday.com/MeetingCoverage/AAOPT/68512?xid=nl_mpt_DHE_2017-10-13&eun=g721819d0r&pos=3